Clinical Microbiology, Virology and Infectious Diseases

Welcome Messaege

9th International Conference on Clinical Microbiology, Virology and Infectious Diseases
February 15–16, 2027 | Tokyo, Japan

Welcome to Microbiology Meet 2027, proudly organized by Conference Series, bringing together the international community working across clinical microbiology, virology, and infectious diseases. With the theme “Bridging Microbial Science and Clinical Research for the Future of Infectious Disease Management,” the conference provides a valuable platform for sharing new research, discussing emerging challenges, and exploring advances shaping the future of infection science.

The meeting welcomes researchers, clinicians, microbiologists, virologists, infectious disease specialists, healthcare professionals, academicians, students, and industry professionals to present their work, exchange ideas, discover new approaches, and establish meaningful international collaborations.

We invite you to present your research, connect with global experts, exchange ideas, and expand your professional network. Microbiology Meet 2027 welcomes both established professionals and early-career researchers to learn, collaborate, and grow.

Set against the vibrant backdrop of Tokyo, Japan, the conference also gives you the opportunity to combine your professional goals with an unforgettable international experience. Attend the conference, advance your scientific connections, and discover the culture, innovation, and beauty of Tokyo—making your participation both professionally rewarding and personally memorable.

About the Conference

Microbiology Meet 2027, the 9th International Conference on Clinical Microbiology, Virology and Infectious Diseases, will be held on February 15–16, 2027, in Tokyo, Japan.

The meeting will address recent work in clinical microbiology, virology, infectious diseases, antimicrobial resistance, emerging and re-emerging infections, microbial diagnostics, vaccines, infection control, and therapeutic research. It will bring together scientists, clinicians, laboratory professionals, academics, researchers, and students to share findings and discuss developments across these areas.

Sessions will include keynote lectures, invited talks, oral presentations, poster presentations, and scientific discussions. The program will encourage the exchange of research findings and practical perspectives on current issues in microbiology and infectious disease research.

Alongside the scientific program, participants will have the opportunity to experience Tokyo, a city known for its blend of modern technology, traditional culture, historic districts, and distinctive urban life.

Participants and Benefits

Featured Audience:

Microbiology Meet 2027 is relevant to professionals and researchers working in:

• Clinical Microbiology
• Virology
• Bacteriology
• Infectious Diseases
• Immunology
• Molecular Microbiology
• Microbial Genetics
• Antimicrobial Resistance
• Epidemiology and Public Health
• Infection Prevention and Control
• Vaccine Research
• Molecular Diagnostics
• Pharmaceutical and Biotechnology Research
• Clinical and Laboratory Research
• Academic and Medical Sciences

The meeting is also suitable for professors, faculty members, research scholars, postdoctoral researchers, PhD students, medical students, laboratory professionals, and representatives from healthcare and life-science organizations.

Participation Benefits

• Present research findings and receive feedback from fellow researchers.
• Follow recent developments in microbiology and infectious disease research.
• Discuss research methods, findings, and practical challenges.
• Meet researchers and professionals from different scientific backgrounds.
• Identify potential areas for research cooperation.
• Learn about developments in diagnostics, vaccines, antimicrobial research, and infection management.
• Develop professional connections within the scientific community.

Early-Career Researcher Benefits

• Present ongoing or completed research.
• Discuss research interests with experienced scientists.
• Learn about current approaches and research directions.
• Establish connections with researchers in related fields.
• Identify opportunities for future academic or research collaboration.
• Gain experience communicating scientific work in an international setting.

Conference Features

• Keynote and Invited Lectures on selected areas of microbiology and infectious diseases
• Scientific Sessions addressing current research topics
• Oral Presentations for research findings and studies
• Poster Presentations for sharing ongoing and completed research
• Young Researcher Sessions for early-career scientists
• Scientific Discussions on current issues and future research directions
• Industry Sessions covering developments in microbiology, diagnostics, and related technologies

Scientific Sessions and Tracks

Track 1: Clinical Microbiology & Diagnostic Medicine

This track will focus on current approaches in clinical microbiology and laboratory diagnosis, with emphasis on accurate pathogen detection, laboratory-based disease investigation, and the application of modern diagnostic methods in clinical practice. It will provide a platform to discuss advances in microbial identification, diagnostic workflows, and technologies supporting timely diagnosis of infectious diseases.

Sub-tracks:

• Clinical Bacteriology, Mycology & Microbial Identification
• Molecular Diagnostics & Rapid Pathogen Detection
• Diagnostic Microbiology, Laboratory Medicine & Point-of-Care Testing

Track 2: Virology & Viral Diseases

This track will explore current research in virology and viral infections, covering viral biology, disease mechanisms, host–virus interactions, emerging viral threats, and developments in diagnosis, prevention, and treatment. It will bring together researchers and clinicians to discuss advances in understanding viral diseases and developing effective approaches for their management.

Sub-tracks:

• Viral Pathogenesis, Host–Virus Interactions & Viral Immunology
• Emerging Viruses, Viral Epidemiology & Molecular Surveillance
• Antiviral Therapies, Vaccines & Viral Diagnostics

Track 3: Antimicrobial Resistance & Stewardship

This track will address the growing challenge of antimicrobial resistance (AMR) and current approaches to responsible antimicrobial use. It will cover resistance mechanisms, surveillance, antimicrobial stewardship, and research into new strategies for preventing and managing resistant infections.

Sub-tracks:

• ·Mechanisms, Genetics & Molecular Epidemiology of Antimicrobial Resistance
• ·Antimicrobial Stewardship, Surveillance & Infection Control
• ·Novel Antimicrobials, Phage Therapy & Alternative Treatment Strategies

Track 4: Emerging & Infectious Diseases

This track will examine emerging and re-emerging infectious diseases, with attention to new pathogens, disease transmission, outbreak investigation, surveillance, and approaches to prevention and control. It will bring together research perspectives on infectious disease threats affecting human and public health.

Sub-tracks:

• Emerging & Re-emerging Pathogens and Infectious Diseases
• Zoonotic, Vector-Borne & Neglected Infectious Diseases
• Disease Surveillance, Outbreak Investigation & Public Health Response

Track 5: Molecular Microbiology & Microbial Genomics

This track will focus on molecular approaches to understanding microorganisms, including microbial genetics, genomics, sequencing, and pathogen characterization. It will highlight how genomic and molecular technologies are being applied to study microbial evolution, transmission, resistance, and disease.

Sub-tracks:

• ·Microbial Genomics, Genetics & Genome Sequencing
• ·Metagenomics, Microbiome Research & Bioinformatics
• ·Molecular Epidemiology, Pathogen Surveillance & Genomic Analysis

Track 6: Immunology & Host–Pathogen Interactions

Understanding how pathogens interact with the human immune system is central to infectious disease research. This track will examine immune recognition, pathogen immune evasion, inflammatory responses, and mechanisms of disease progression, with discussion of how immunological knowledge can support improved diagnostics, preventive strategies, and therapeutic development.

Sub-tracks:

• Innate & Adaptive Immune Responses to Infection
• Host–Pathogen Interactions & Immune Evasion Mechanisms
• Immunopathogenesis, Inflammation & Immunotherapeutic Approaches

Track 7: Vaccines & Immunization Research

Vaccination remains an important area of infectious disease prevention and biomedical research. This track will cover vaccine design, immune responses, novel vaccine platforms, and clinical evaluation, safety, and immunization strategies, with attention to advances that can improve protection against infectious pathogens.

Sub-tracks:

• Vaccine Design, Development & Novel Vaccine Platforms
• Vaccine Immunology, Safety & Clinical Evaluation
• Immunization Strategies, Vaccine Effectiveness & Population Health

Track 8: Infection Prevention & Control

Effective infection prevention requires coordinated approaches across healthcare settings, laboratories, and communities. This track will examine infection transmission, healthcare-associated infections, surveillance systems, environmental controls, and evidence-based prevention practices, with emphasis on reducing avoidable infections and strengthening infection control programs.

Sub-Tracks:

• Healthcare-Associated Infections & Hospital Infection Control
• Antimicrobial Resistance Prevention & Infection Surveillance
• Infection Prevention Strategies, Outbreak Response & Public Health Preparedness

Sub-tracks:

Track 9: Bacterial Pathogenesis & Host–Pathogen Interactions

Bacterial pathogenesis involves complex interactions between microorganisms and their hosts, influencing infection, disease progression, and treatment outcomes. This track will explore bacterial virulence, host–pathogen interactions, immune evasion, bacterial persistence, biofilm formation, and emerging therapeutic approaches, providing a platform for discussing advances in understanding and controlling bacterial infections.

Sub-tracks:

• Bacterial Virulence, Toxins & Pathogenic Mechanisms
• Host–Pathogen Interactions, Immune Evasion & Host Responses
• Biofilms, Bacterial Persistence & Novel Antivirulence Strategies

Track 10: Emerging & Re-Emerging Infectious Diseases

The emergence and re-emergence of infectious diseases continue to pose significant challenges to global health. This track will examine novel pathogens, disease outbreaks, zoonotic infections, antimicrobial resistance, surveillance systems, and pandemic preparedness, with emphasis on advancing early detection, prevention, and effective response strategies.

Sub-tracks:

• Emerging Pathogens, Novel Infections & Disease Outbreaks
• Zoonotic Diseases, One Health & Global Disease Surveillance
• Pandemic Preparedness, Outbreak Response & Infectious Disease Control

Track 11: Vaccine Development, Trials & Translational Research

Vaccine development combines advances in immunology, molecular biology, biotechnology, and clinical research to create safe and effective approaches for disease prevention. This track will explore vaccine discovery, preclinical studies, clinical trials, immunogenicity, safety evaluation, translational research, and strategies for moving promising vaccine candidates from laboratory research to clinical application.

Sub-tracks:

• Preclinical Vaccine Research, Antigen Discovery & Vaccine Design
• Clinical Trials, Vaccine Safety & Immunogenicity
• Translational Vaccinology, Vaccine Optimization & Clinical Applications

Track 12: Vaccine Safety, Surveillance & Pharmacovigilance

Ensuring vaccine safety is essential for maintaining public confidence and supporting effective immunization programs. This track will examine vaccine safety assessment, adverse events following immunization, pharmacovigilance systems, post-marketing surveillance, risk assessment, and real-world safety monitoring, with emphasis on strengthening evidence-based vaccine safety practices.

Sub-tracks:

• Adverse Events Following Immunization & Vaccine Safety Assessment
• Post-Marketing Surveillance, Pharmacovigilance & Risk Management
• Real-World Vaccine Safety, Monitoring Systems & Regulatory Evaluation

Track 13: Next-Generation Vaccines & Vaccine Technologies

Next-generation vaccine technologies are transforming the prevention and control of infectious diseases through innovative platforms and advanced delivery systems. This track will explore mRNA vaccines, DNA and recombinant vaccines, viral vectors, nanoparticle-based platforms, novel adjuvants, thermostable formulations, and advanced vaccine delivery technologies, highlighting emerging innovations that can improve vaccine effectiveness, accessibility, and scalability.

Sub-tracks:

• mRNA, DNA, Recombinant & Viral Vector Vaccine Platforms
• Nanotechnology, Novel Adjuvants & Advanced Vaccine Delivery Systems
• Universal Vaccines, Thermostable Formulations & Innovative Vaccine Technologies

Track 14: One Health, Zoonoses & Global Health

The interconnected health of humans, animals, and ecosystems plays a major role in the emergence and transmission of infectious diseases. This track will examine zoonotic infections, environmental microbiology, cross-species transmission, antimicrobial resistance, and integrated One Health surveillance approaches.

Sub-tracks:

• Zoonotic Pathogens, Spillover Events & Cross-Species Transmission
• Environmental Microbiology, One Health Surveillance & Disease Prevention
• Animal–Human Interfaces, AMR & Global Infectious Disease Control

Track 15: AI, Digital Microbiology & Computational Vaccinology

Artificial intelligence and computational technologies are opening new possibilities for pathogen surveillance, vaccine design, diagnosis, and drug discovery. This track will focus on AI-driven diagnostics, computational vaccinology, predictive modelling, machine learning, and data-driven infectious disease research.

Sub-tracks:

• AI-Driven Pathogen Detection, Diagnosis & Disease Prediction
• Computational Vaccine Design, Antigen Discovery & Epitope Prediction
• Machine Learning, Genomic Data Analysis & Digital Epidemiology

Track 16: Vaccine Strategies for Emerging & Neglected Diseases

Developing vaccines for emerging, re-emerging, and neglected infectious diseases remains an important area of global research. This track will explore new vaccine candidates, pathogen-specific strategies, outbreak-responsive vaccination, neglected tropical diseases, and approaches to improving protection against challenging infectious agents.

Sub-tracks:

• Vaccines for Emerging & Re-Emerging Infectious Diseases
• Neglected Tropical Disease Vaccines & Global Vaccine Research
• Rapid Vaccine Development, Pandemic Response & Outbreak Vaccination

Track 17: Bacteriophages, Phage Therapy & Phage Biology

Bacteriophages are viruses that specifically infect bacteria and are increasingly studied as potential tools for addressing bacterial infections, antimicrobial resistance, diagnostics, microbiome modulation, and biotechnology. This track will explore advances in phage biology, phage–host interactions, therapeutic applications, phage engineering, phage resistance, and translational research, with emphasis on moving promising phage-based approaches toward clinical and practical applications.

Sub-Tracks:

• Phage Discovery, Isolation & Characterization
• Phage–Host Interactions & Host Range
• Phage Applications in Food Safety & Agriculture

Track 18: Vaccination & Global Health Security

Vaccination is a fundamental component of global health security and plays an important role in preventing infectious diseases, reducing transmission, protecting vulnerable populations, and strengthening preparedness for outbreaks and pandemics. This track will explore advances in global immunization strategies, outbreak vaccination, vaccine preparedness, equitable access, immunization systems, and international approaches to infectious disease prevention. It will provide a platform for researchers, healthcare professionals, public-health experts, policymakers, and vaccine developers to discuss strategies for strengthening vaccination programs and improving global preparedness for emerging and re-emerging infectious diseases.

Sub-Tracks:

• Global Immunization Programs & Strategies
• Vaccine-Preventable Diseases & Disease Elimination
• Pandemic Preparedness & Vaccine Response

Market Analysis Report: Clinical Microbiology, Virology & Infectious Diseases

Market Overview

The global Clinical Microbiology, Virology and Infectious Diseases sector is experiencing continued growth due to the increasing need for rapid disease diagnosis, antimicrobial-resistance testing, molecular diagnostics, pathogen surveillance, genomic technologies and pandemic preparedness.

Since clinical microbiology, virology and infectious-disease diagnostics are measured as separate market categories by different research organizations, market values can vary depending on the products and services included.

Regional Market Highlights

North America

North America represents a major market for clinical microbiology and infectious-disease diagnostics, supported by advanced healthcare infrastructure, high diagnostic adoption, research investment and established laboratory networks.

Europe

Europe has strong activity in infectious-disease surveillance, antimicrobial-resistance research, molecular diagnostics, pathogen genomics and public-health preparedness.

Asia-Pacific

Asia-Pacific is one of the fastest-growing regions due to expanding healthcare infrastructure, increasing diagnostic testing, population growth and rising investment in infectious-disease research.

India

India's infectious-disease diagnostics market is estimated at approximately USD 714.9 million in 2025 and is projected to reach approximately USD 1.35 billion by 2030, representing a 13.6% CAGR.

Key Market Figures

Future Outlook: 

The convergence of clinical microbiology, virology, molecular diagnostics, genomics, artificial intelligence, antimicrobial-resistance research and global health surveillance is expected to create continued opportunities for scientific research and technological development.

For a Clinical Microbiology, Virology and Infectious Diseases conference, the most relevant market-growth themes include rapid diagnostics, AMR, pathogen genomics, emerging infectious diseases, vaccine research, AI in microbiology, microbiome science, phage therapy, global health security and pandemic preparedness.